BioCentury
ARTICLE | Financial News

Sarepta prices upsized $325.1M follow-on

July 25, 2017 6:57 PM UTC

Sarepta Therapeutics Inc. (NASDAQ:SRPT) raised $325.1 million through the sale of 7.7 million shares at $42.50 in a follow-on underwritten by Goldman Sachs, JPMorgan, Credit Suisse, Baird, Nomura and William Blair. The price is a 2% discount to Sarepta's closing price July 21 of $43.41, before the offering was announced.

Sarepta proposed before market hours Monday to raise $250 million. Its shares rose $0.54 to $43.95 on Monday, and were down $0.75 to $43.20 in afternoon trading Tuesday...

BCIQ Company Profiles

Sarepta Therapeutics Inc.